Skip to main navigation
Telix Pharmaceuticals Limited Logo
  • Overview
  • News
  • Events & Presentations
    • Events
    • Presentations
  • Financials
    • Half-year & Quarterly Results
    • Annual Reports & AGMs
    • ASX Announcements
    • SEC Filings
  • Pipeline
  • Stock
    • Stock Quote & Chart
    • Analyst Coverage
  • Corporate Governance
    • Board & Management
    • Documents & Charters
    • Sustainability
  • Resources
    • Shareholder Information
    • Investor Resources
    • Email Alerts
    • Contact Us

Half-year & Quarterly Results

Show all

2026

Q1

  • Earnings Release

2025

FY

  • Earnings Release
  • 2025 Annual Report

Q4

  • Earnings Release

Q3

  • Earnings Release

H1

  • Results Release
  • Interim Report
  • Webcast

Q2

  • Earnings Release

Q1

  • Earnings Release

2024

Q4

  • Earnings Release

Q3

  • Earnings Release

H1

  • Results Release
  • Results Webcast

Q1

  • Earnings Release

Subscribe to our Email Alerts

©2026 Telix Pharmaceuticals Limited.

The Telix Pharmaceuticals and the Illuccix name and logo are trademarks of Telix Pharmaceuticals Limited and its affiliates – all rights reserved. This website is intended for corporate communication and investor relations purposes only and is not intended as promotion or advertising to any audience in any country worldwide.

Privacy Policy. Terms of Use. Cookies Policy. Forward Looking Statements
  • Twitter
  • LinkedIn
  • Facebook
  • YouTube
Search Investors